Company Comparison
NeuroLink Therapeutics vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | NeuroLink Therapeutics | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Cambridge | — |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | Series A | — |
| Total Funding | $45M | — |
| Valuation | — | — |
What They Build
NeuroLink Therapeutics
A Cambridge-based biotech company developing neurological therapeutics and treatments.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
NeuroLink Therapeutics
No investors listed.
Sector Overlap
Both NeuroLink Therapeutics and 10x Genomics operate in Biotech.
Browse all Biotech companies →